Term
- epitope recognition of these two immunoglobulins creates all five types of antibodies |
|
Definition
|
|
Term
- these are the co-receptors for sIgM BcR receptors and they initiate intracellular signaling pathways |
|
Definition
|
|
Term
- a T-Dependent antigen requires this secondary linkage between the B lymphocytes and the T Helper cells before cytokines are produced |
|
Definition
|
|
Term
- the first signal in B cell proliferation requires binding of this type of antigen |
|
Definition
|
|
Term
- most common antibody (75-80% of total)
- has four subisotypes (which differ at the hinge only)
- ONLY antibody that can cross the placenta
- activates complement, neutralizes toxins and viruses, immobilizes mobile bacteria, coats it for phagocytosis |
|
Definition
|
|
Term
- predominant subclass of IgG |
|
Definition
|
|
Term
- type of immunity passed from mother to fetus via IgG crossing the placenta via FcRn
- Example: anti-tetanus toxin |
|
Definition
|
|
Term
- FcRn have a similar structure to this type of molecule |
|
Definition
|
|
Term
- number of FcRn required to bind to IgG to successfully transfer it from the maternal blood to the extracellular spaces |
|
Definition
|
|
Term
- order in which Ig's are synthesized from fetal life into birth |
|
Definition
GAMDE (16,4,2,1ish,symptomatic) |
|
|
Term
- IgG can form lattice formations via these 2 mechanisms |
|
Definition
Agglutination (clumping of insoluble antigens)
&
Precipitation |
|
|
Term
- after an Fc binds a NK cell the natural killer is called this |
|
Definition
Antibody-dependent, cell-mediated cytotoxic cell (ADCC) |
|
|
Term
- abbreviation/receptor associated with Natural Killer cells |
|
Definition
|
|
Term
- called the secretory antibody because it is bound in MALT, GALT, GI and respiratory tracts
- found in serum as monomer and as a dimer in secretions (saliva, mucus, sweat, tears, milk [colostrum], GI fluid)
- DOES NOT activate complement
- good with antivirus
- has 4 constant domains |
|
Definition
|
|
Term
- the cysteine-rich joining component of IgA that creates the dimer in preparation of secretion |
|
Definition
|
|
Term
- the J chain joins these parts of IgA |
|
Definition
|
|
Term
- the stabilizing secretory component that protects the IgA2 dimer from proteolysis originates on this
- mediates the transport of the IgA dimer to the luminal surface |
|
Definition
|
|
Term
- 19s gammaglobulin with a mw of 900000
- pentameric with 4 constant domains
- primary activator of complement
- the antibody involved in the natural RBC antigen recognition of the ABO blood groups |
|
Definition
|
|
Term
- an elevated IgM level could indicate this condition and time frame |
|
Definition
Recent infection
(because IgM is 1st to appear in response to antigenic stimulation) |
|
|
Term
- elevated levels of IgM can indicate congenital or perinatal infections in this population |
|
Definition
|
|
Term
- antibody that is most susceptible to proteolytic degradation
- usually associated with sIgM on B lymphocytes
- first identified in a case of multiple myeloma |
|
Definition
|
|
Term
- the cytotrophic/reaginic antibody primarily associated with allergies
- has a very low half life (2 days) in circulation, but can persist on mast cells and basophils for MUCH longer
- causes an immediate hypersensitivity to allergens
- can protect against certain worm infections (Helminths) |
|
Definition
|
|
Term
- cell surface molecules with polypeptide chains with folded regions or domains can belond to this group |
|
Definition
|
|
Term
- phase of the humoral immune response that occurs just after the primary vaccination (or antigen exposure)
- IgM appears 1st followed by IgG
~ 1-2 weeks in duration |
|
Definition
|
|
Term
- following the exponential phase where antibody production is amplified, this phase represents the balance of production and degradation |
|
Definition
|
|
Term
- these cells are triggered following an anamnestic, secondary or booster response |
|
Definition
|
|
Term
- this effect is experienced regarding the lag phase following a secondary response to the same antigen
- this effect is experienced regarding the production of IgG following an anamnestic response |
|
Definition
shorter lag phase
greater production of IgG for longer |
|
|
Term
- this is given to a mother post-delivery when she gives birth to her first Rh+ baby as an Rh- mother
- hemolytic disease of the newborn can preceed administration of this
- constitutes artificial passive immunity |
|
Definition
|
|